Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income	Total
Beginning balance, shares at Dec. 31, 2017	0	124,273,548
Beginning balance, value at Dec. 31, 2017	$ 0	$ 124,274	$ 47,901,532	$ (40,843,568)	$ (77,344)	$ 7,104,894
Net income (loss)				(1,091,122)		(1,091,122)
Change in foreign currency translation					(41,595)	(41,595)
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares		256,455
Issuance of common stock in connection with the exercise of common stock purchase warrants, value		$ 256	61,244			61,500
Issuance of common stock as compensation to employees, officers and/or directors, shares		115,321
Issuance of common stock as compensation to employees, officers and/or directors, value		$ 115	76,078			76,193
Issuance of common stock in exchange for consulting, professional and other services, shares		197,500
Issuance of common stock in exchange for consulting, professional and other services, value		$ 197	138,178			138,375
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, shares		285,627
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, value		$ 286	171,090			171,376
Issuance of common stock in connection with the issuance of convertible debentures, shares		186,566
Issuance of common stock in connection with the issuance of convertible debentures, value		$ 187	109,652			109,839
Issuance of common stock in connection with the admendment of terms of promissory note(s), shares		800,000
Issuance of common stock in connection with the admendment of terms of promissory note(s), value		$ 800	479,200			480,000
Beneficial conversion feature			800			800
Ending balance, shares at Mar. 31, 2018	0	126,115,017
Ending balance, value at Mar. 31, 2018	$ 0	$ 126,115	48,937,774	(41,934,690)	(118,939)	7,010,260
Beginning balance, shares at Dec. 31, 2018		138,553,655
Beginning balance, value at Dec. 31, 2018		$ 138,554	52,254,286	(45,457,207)	(153,254)	6,782,379
Net income (loss)				(1,643,639)		(1,643,639)
Change in foreign currency translation					11,104	11,104
Issuance of preferred stock in connection with sales made under private offerings, shares	800,000
Issuance of preferred stock in connection with sales made under private offerings, value	$ 800		354,795			355,595
Issuance of common stock in connection with sales of Series A preferred stock, shares		4,000,000
Issuance of common stock in connection with sales of Series A preferred stock, value		$ 4,000	440,405			444,405
Issuance of common stock in exchange for consulting, professional and other services, shares		1,377,338
Issuance of common stock in exchange for consulting, professional and other services, value		$ 1,377	348,268			349,645
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, shares		99,720
Issuance of common stock in lieu of cash for loans payable and other accrued obligations, value		$ 100	26,840			26,940
Issuance of common stock in connection with the admendment of terms of promissory note(s), shares		800,000
Issuance of common stock in connection with the admendment of terms of promissory note(s), value		$ 800	219,200			220,000
Beneficial conversion feature			199,800			199,800
Deemed dividend on conversion of convertible preferred stock to common stock			(199,800)			(199,800)
Accretion of Series A preferred stock			440,405			444,405
Deemed dividend on accretion of Series A preferred stock			(440,405)			(440,405)
Ending balance, shares at Mar. 31, 2019	800,000	144,830,713
Ending balance, value at Mar. 31, 2019	$ 800	$ 144,831	$ 53,643,794	$ (47,100,846)	$ (142,150)	$ 6,546,429